Tamara Bohlig
Axos FinancialAbout Tamara N. Bohlig
Independent Class I director of Axos Financial, Inc. since August 2019; age 56. She brings 30+ years of experience across technology, financial services, and health care, having led corporate and product marketing for more than 30 products/services and the marketing of 250+ investment products and 100+ platform services. Currently CMO of Vida Health and a small business owner-operator; prior roles include CMO at AssetMark and SmartBiz Loans (helped take AssetMark public), senior executive roles at Charles Schwab, and earlier marketing/product roles at JPMorgan Chase (WaMu/Providian), Hewlett-Packard, Procter & Gamble, and General Mills. Education: MBA (Kellogg School of Management) and BA in Sociology, Northwestern University .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| AssetMark | Chief Marketing Officer | Not disclosed | Helped take asset management platform public on NYSE |
| SmartBiz Loans | Chief Marketing Officer | Not disclosed | Senior marketing leadership |
| Charles Schwab & Co., Inc. | Senior executive (BD, client experience, marketing) | Not disclosed | Led functions across investor retail and investment management divisions |
| JPMorgan Chase (WaMu, Providian) | Vice President, Marketing | Not disclosed | Product marketing leadership |
| Hewlett-Packard | Product management/sales/marketing | Not disclosed | Product and marketing roles |
| Procter & Gamble | Marketing | Not disclosed | Brand/marketing roles |
| General Mills | Sales/marketing | Not disclosed | Sales and marketing roles |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Vida Health | Chief Marketing Officer | Current | Executive leadership; health tech domain expertise |
| Small business (not named) | Owner-operator | Current | Entrepreneurial operator |
Board Governance
- Independence: Board determined 10 of 11 directors are independent under NYSE rules; Bohlig is identified as an Independent Director .
- Board class and term: Class I; term expires at the 2026 Annual Meeting .
- Committee memberships:
- Axos Financial (Company): None .
- Axos Bank (subsidiary): Compliance and Independent Credit Review (Chair); Technology .
- Attendance: FY2025 Board met 16 times; Axos Bank board met 21 times; directors attended more than 75% of meetings on committees they served; all directors attended the Nov 14, 2024 Annual Meeting .
- Committee activity FY2025:
- Audit: 11 meetings (Chair: Paul J. Grinberg) .
- Compensation: 6 meetings (Chair: James J. Court) .
- Nominating/Corporate Governance: 2 meetings (Chair: Stefani D. Carter) .
Fixed Compensation
| Fiscal Year | Cash Fees (USD) | Notes |
|---|---|---|
| FY2024 | $40,000 | Standard non-employee director cash retainer |
| FY2025 | $42,333 | Annual cash payments structure effective Nov 14, 2024; standard director retainer set at $44,000 (pro-rated amounts may apply) |
- Cash retainer schedule commencing Nov 14, 2024: Other non-employee directors $44,000; committee chair premiums: Audit $29,000 (total $73,000), Compensation $15,000 (total $59,000); Chairman of the Board total $117,000; Vice-Chairman total $73,000 .
Performance Compensation
| Grant Date | RSUs (#) | Base Price per Unit | Grant-Date Fair Value (USD) | Vesting Terms |
|---|---|---|---|---|
| 8/31/2023 | 6,000 | $43.09 | $258,540 | Annual RSUs for non-employee directors fully vest on the anniversary of grant; at vest, each RSU converts into one common share |
| 11/14/2024 | 4,289 | $80.58 | $345,608 | Annual RSUs fully vest on the anniversary of grant (dollar-denominated RSU structure adopted) |
- Structure change: In Nov 2024, RSU grants timing moved to immediately after the annual meeting and structure changed from fixed-share to dollar-denominated awards, per recommendation of independent consultant F.W. Cook .
- Plan provisions: 2014 Stock Incentive Plan includes stockholder-friendly terms—no evergreen/repricing, no tax gross-ups, no dividends on unvested awards, double-trigger change-in-control, and director stock ownership requirement of 5x annual cash retainer .
Other Directorships & Interlocks
| Company | Role | Committee Roles | Status |
|---|---|---|---|
| — | — | — | No other public company directorships disclosed for Ms. Bohlig in AX’s proxy materials |
Expertise & Qualifications
- Deep go-to-market leadership across fintech/asset management/brokerage; led launch and management of 30+ products/services and marketing of 250+ investment products and 100+ platform services .
- Executive experience in public company context (AssetMark IPO) and at major financial institutions (Charles Schwab; JPMorgan Chase) .
- Education: MBA (Kellogg), BA (Northwestern) .
Equity Ownership
| Holder | Shares Beneficially Owned | Percent of Outstanding Shares |
|---|---|---|
| Tamara N. Bohlig | 17,208 | * (Less than one percent) |
- Director stock ownership guideline: Minimum of 5x annual cash retainer; five-year transition period to comply .
- Insider Trading Policy: Prohibits pledging, short sales, derivative transactions in Company securities without prior CFO consent; broadly restricts speculative transactions and pledging .
Governance Assessment
- Board effectiveness: Bohlig is an independent director with domain expertise in fintech and marketing; chairs the Bank’s Compliance and Independent Credit Review Committee, indicating engagement with risk controls and credit governance . Independence affirmed alongside a board where 10/11 directors are independent .
- Alignment: Director pay is majority equity via RSUs; stock ownership guidelines (5x cash retainer) and time-based vesting support alignment, with no tax gross-ups/dividends on unvested awards and double-trigger CIC protection in the plan .
- Attendance/engagement: Board/Bank meetings were frequent (16 and 21 respectively), and directors met the >75% attendance threshold; all attended the 2024 annual meeting—acceptable engagement signal .
- Compensation oversight: Independent consultant F.W. Cook retained; RSU structure moved to dollar-denominated grants post annual meeting to reflect best practices .
- Investor signals: 2025 Say-on-Pay support recorded at 25,671,253 For vs 18,081,439 Against; share plan amendment passed with 27,625,699 For vs 16,153,783 Against—adequate but not overwhelming support, suggesting balanced investor sentiment on compensation/equity usage .
- Conflicts/related-party exposure: Board affirmed director independence after reviewing relevant relationships; no director perquisites above reportable thresholds; insider policy restricts pledging/hedging—no specific related-party transactions disclosed involving Bohlig .
RED FLAGS: None disclosed specific to Bohlig. Broader governance watchpoints include moderate dissent on say-on-pay and equity plan—monitor future votes and any shifts in director equity grant sizing .